论文部分内容阅读
国家医药管理局近日确定了我国医药经济结构调整的总体目标:以市场为导向,以提高经济效益为中心,通过资产重组、兼并破产、技术进步及适当扩大投资,到2000年基本形成以国有(或控股)大型企业为主体、多种经济成分协调发展,产业结构、企业组织结构和产品结构基本合理的医药经济结构。 ——企业组织结构目标:到2000年,全行业存量资产进一步优化配置,基本形成在专业化协作基础上高度集中的大型企业集团与适度分散的中小型专业化企业相结合、能较好地发挥已有生产能力的企业组织结构。全国有2-3家销售额超100亿元、10家销售
The State Administration of Pharmaceuticals has recently determined the overall objective of China’s pharmaceutical economic restructuring: market-oriented, economic efficiency-centered, asset restructuring, mergers and bankruptcy, technological progress, and appropriate expansion of investment, and by the year 2000, it will be basically state-owned ( Or holding) large-scale enterprises as the main body, a variety of economic components coordinated development, industrial structure, corporate organizational structure and product structure are basically rational pharmaceutical economic structure. ——Corporate organizational structure Goal: By the year 2000, the industry-wide stock of assets will be further optimized and allocated, and large-scale enterprise groups that are highly concentrated on the basis of specialized cooperation will be combined with moderately decentralized small and medium-sized specialized enterprises, and will be able to play better. Existing organizational structure of production capacity. There are 2-3 sales in China exceeding 10 billion yuan and 10 sales